医药生物行业业绩前瞻:73家预喜,荣昌生物、君实生物-U、华仁药业等预亏超过5亿元

面包财经
17 Feb

根据申万一级行业分类,截至2025年2月14日收盘,共有257家医药生物行业A股上市公司披露2024年业绩预告。业绩预喜的医药生物企业合计73家,其中43家企业预增,23家企业扭亏,7家企业略增。具体来说,百利天恒-U、达仁堂、东阿阿胶等9家企业预告净利润下限超过10亿元。荣昌生物、君实生物-U、华仁药业等20家企业预告2024年净利润上限亏损超过5亿元。73家业绩预喜,百利天恒-U、达仁堂利润...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10